Coya Therapeutics (COYA) Institutional Ownership → Exposed: 10 CENT Crypto to Explode April 20th? (From True Market Insiders) (Ad) Free COYA Stock Alerts $8.41 +0.39 (+4.86%) (As of 04:00 PM ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Coya Therapeutics (NASDAQ:COYA)CurrentInstitutional OwnershipPercentage39.75%Number ofInstitutional Buyers(last 12 months)4TotalInstitutional Inflows(last 12 months)$10.11MNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$550.41K Get COYA Insider Trade Alerts Want to know when executives and insiders are buying or selling Coya Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data COYA Institutional Buying and Selling by Quarter Ad True Market InsidersExposed: 10 CENT Crypto to Explode April 20th?Former Wall Street Insider and Professional Money Manager Reveals 4 Cryptos BETTER Than BitcoinClick For My #1 FREE Crypto for 2024 Coya Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/15/2024Greenlight Capital Inc.1,274,026$9.44M0.5%+172.2%12.702% 2/12/2024AIGH Capital Management LLC1,031,977$7.38M2.9%+92.6%10.289% 2/9/2024Worth Venture Partners LLC92,667$687K0.4%-30.8%0.924% 11/15/2023Worth Venture Partners LLC134,006$519K0.3%-8.5%1.336% 11/13/2023AIGH Capital Management LLC535,794$2.06M1.0%-8.7%5.342% 11/7/2023CM Management LLC100,000$384K0.4%+66.7%1.005% 8/14/2023 Mirador Capital Partners LP15,361$63K0.0%N/A0.154% 8/4/2023CM Management LLC60,000$244K0.2%N/A0.603% 2/16/2023AIGH Capital Management LLC560,000$2.65M0.9%N/A5.785% (Data available from 1/1/2016 forward) COYA Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of COYA shares? During the previous two years, the following institutional investors and hedge funds held shares of Coya Therapeutics shares: Greenlight Capital Inc. ($9.44M), AIGH Capital Management LLC ($7.38M), Worth Venture Partners LLC ($687K), and CM Management LLC ($384K), Mirador Capital Partners LP ($63K).Learn more on COYA's institutional investors. What percentage of Coya Therapeutics stock is owned by institutional investors? 39.75% of Coya Therapeutics stock is owned by institutional investors. Learn more on COYA's institutional investor holdings. Which institutional investors have been buying Coya Therapeutics stock? The following institutional investors have purchased Coya Therapeutics stock in the last 24 months: AIGH Capital Management LLC ($1.06M), Greenlight Capital Inc. ($805.96K), CM Management LLC ($100K), and Mirador Capital Partners LP ($15.36K). How much institutional buying is happening at Coya Therapeutics? Institutional investors have bought a total of 1,977,503 shares in the last 24 months. This purchase volume represents approximately $12.76M in transactions. Which Coya Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Coya Therapeutics stock in the last 24 months: Worth Venture Partners LLC ($53.83K), and AIGH Capital Management LLC ($51.08K). How much institutional selling is happening at Coya Therapeutics? Institutional investors have sold a total of 104,904 shares in the last 24 months. This volume of shares sold represents approximately $550.41K in transactions. Related Companies: Citius Pharmaceuticals Institutional Ownership Societal CDMO Institutional Ownership OptiNose Institutional Ownership Immunic Institutional Ownership Repare Therapeutics Institutional Ownership Adagene Institutional Ownership Nuvectis Pharma Institutional Ownership Vistagen Therapeutics Institutional Ownership CytomX Therapeutics Institutional Ownership Eliem Therapeutics Institutional Ownership This page (NASDAQ:COYA) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersThis Apple-like Innovator is Revolutionizing HealthcareWall Street Startop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersPentagon contract could send this $2 AI stock soaringBehind the MarketsThe #1 Crypto for 2024InvestorPlaceDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Coya Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.